
Peptides
Subcategories of "Peptides"
Found 29634 products of "Peptides"
NOV Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NOV antibody, catalog no. 70R-1715Purity:Min. 95%HAS3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of HAS3 antibody, catalog no. 70R-7389
Purity:Min. 95%OTUD6A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of OTUD6A antibody, catalog no. 70R-9720
Purity:Min. 95%SLC6A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC6A1 antibody, catalog no. 70R-6761
Purity:Min. 95%Anti GIP (Rat) Serum
Anti-GIP (Rat) Serum is a recombinant, affinity-purified antibody that recognizes the peptide sequence of rat GIP. Anti-GIP (Rat) Serum is an important research tool used in the study of protein interactions, activation, ligand binding, and receptor activation. It can also be used to inhibit GIP activity by blocking the binding site on the receptor. Anti-GIP (Rat) Serum is available in high purity and at competitive pricing.Purity:Min. 95%Lipid A (E. coli)
Lipid A is a component of the outer membrane of Gram-negative bacteria. Lipid A is a complex molecule that is composed of three major domains: an amino-terminal domain, a lipid tail, and a carboxy-terminal domain. The amino-terminal domain contains two receptor binding sites that are responsible for activating the innate immune system. Peptides in the amino-terminal domain bind to Toll-like receptor 4 (TLR4) and activate macrophages, which release inflammatory cytokines and nitric oxide. The lipid tail interacts with CD14 on macrophages, which leads to the activation of nuclear factor κB (NFκB). Activation of TLR4 and CD14 causes an increase in the production of proinflammatory cytokines. The carboxy-terminal domain binds to lipopolysaccharide (LPS) and prevents LPS from interacting with TLR4. The purified Lipid A is free from otherFormula:C94H178N2O25P2Purity:Min. 95%Molecular weight:1,798.4 g/molGOLGA7 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACSL5 antibody, catalog no. 70R-6556Purity:Min. 95%Cytokeratin 19 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT19 antibody, catalog no. 70R-2947Purity:Min. 95%PNPLA8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PNPLA8 antibody, catalog no. 70R-2261Purity:Min. 95%GHR Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GHR antibody, catalog no. 70R-7290Purity:Min. 95%TM2D2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TM2D2 antibody, catalog no. 70R-10119
Purity:Min. 95%Alarelin
Alarelin is a peptide hormone that is released by the posterior lobe of the pituitary gland. It regulates the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior lobe of the pituitary gland, which regulates ovulation and testosterone production in males. Alarelin can be used to induce ovulation in women who are undergoing fertility treatments or to stimulate FSH and LH levels in men with low testosterone. Alarelin is also used as an experimental treatment for male infertility. Alarelin has been shown to act as a gonadotrophin-releasing hormone (GnRH) agonist, exerting its action through binding to GnRH receptors found on cells in the hypothalamus, causing them to release hormones that stimulate the pituitary gland. This drug has a molecular mass of 534 Da and a stable peptide structure with no significant degradation products observed following freeze-dried or desiccatedPurity:Min. 95%RAB2B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RAB2B antibody, catalog no. 70R-10148Purity:Min. 95%CLU Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLU antibody, catalog no. 70R-10249Purity:Min. 95%Azido-dPEG® 8-NHS ester
CAS:Azido-dPEG® 8-NHS ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. Azido-dPEG® 8-NHS ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:564.58 g/molRFRP-1 (Human)
Custom research peptide; min purity 95%.Formula:C67H101N19O14SPurity:Min. 95%Molecular weight:1,428.73 g/molSynaptogyrin 4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SYNGR4 antibody, catalog no. 70R-6866Purity:Min. 95%SLC23A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC23A2 antibody, catalog no. 70R-6281Purity:Min. 95%SPDP-dPEG®8-NHS Ester
SPDP-dPEG®8-NHS Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. SPDP-dPEG®8-NHS Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.
Purity:Min. 95%PPIH Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIH antibody, catalog no. 70R-3818Purity:Min. 95%EEF2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EEF2 antibody, catalog no. 70R-2318Purity:Min. 95%TAAR5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TAAR5 antibody, catalog no. 70R-9833Purity:Min. 95%Pneumadin (rat)
CAS:Please enquire for more information about Pneumadin (rat) including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormula:C47H74N12O15Molecular weight:1,047.18 g/molAmylin (8-37),rat
Custom research peptide; min purity 95%.Formula:C140H227N43O43Purity:Min. 95%Molecular weight:3,200.63 g/molRALY Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RALY antibody, catalog no. 70R-3973Purity:Min. 95%SLC43A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC43A2 antibody, catalog no. 70R-6270Purity:Min. 95%PB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192Purity:Min. 95%THYN1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of THYN1 antibody, catalog no. 70R-4037Purity:Min. 95%RP13-102H20.1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of RP13-102H20.1 antibody, catalog no. 70R-7518Purity:Min. 95%PML Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PML antibody, catalog no. 70R-7965Purity:Min. 95%Ac-Gly-Lys-OMe • AcOH [AGLME]
CAS:Ac-Gly-Lys-OMe • AcOH is a synthetic substrate that is used in enzymatic reactions. This product is a peptide that contains an amide bond and a disulfide bond. It has been shown to be inactive when exposed to human serum for up to 30 minutes. Ac-Gly-Lys-OMe • AcOH has been shown to have inhibitory effects on the activity of monoclonal antibodies as well as dodecyl, which belongs to the group of lipids found in blood plasma. The rate of this reaction increases with increasing temperature and pH, but decreases with increasing concentrations of AGLME or dodecanol.Formula:C11H21N3O4•CH3COOHPurity:Min. 95%Molecular weight:319.35 g/molMitofusin 2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MFN2 antibody, catalog no. 70R-6461Purity:Min. 95%NSUN6 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of NSUN6 antibody, catalog no. 70R-4985Purity:Min. 95%GnGn-bi-Asn-PABA
GnGn-bi-Asn-PABA is a peptide that has been shown to activate the nicotinic acetylcholine receptor. It binds to the ligand binding site of the receptor and mimics the natural neurotransmitter acetylcholine, increasing the probability of neurotransmitter release. GnGn-bi-Asn-PABA has also been shown to inhibit calcium ion channels and ligand gated ion channels, which are proteins that regulate the flow of ions in and out of cells. GnGn-bi-Asn-PABA is a research tool used for studying cell biology and pharmacology.Formula:C63H103N9O37Purity:Min. 95%Molecular weight:1,578.5 g/molDOTA-tris(Acid)-Amido-dPEG®24-TFP Ester
DOTA-tris(Acid)-Amido-dPEG®24-TFP Ester is a PEG compound with two different functional groups (also known as heterobifunctional). Unlike homobifunctional PEG compounds (same functional group on both ends), this type of compounds are more versatile as have two different anchor points. DOTA-tris(Acid)-Amido-dPEG®24-TFP Ester is used as a linker and spacer to add a PEG moiety, via pegylation (a bioconjugation technique) to proteins, peptides, oligonucleotides, small molecules and nanoparticles.Purity:Min. 95%Molecular weight:1,908.86 g/molARMCX3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ARMCX3 antibody, catalog no. 70R-7415Purity:Min. 95%CACYBP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CACYBP antibody, catalog no. 70R-1064Purity:Min. 95%PPP1R8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PPP1R8 antibody, catalog no. 70R-4733Purity:Min. 95%SEMA6A Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SEMA6A antibody, catalog no. 70R-7134Purity:Min. 95%CLN8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLN8 antibody, catalog no. 70R-7115Purity:Min. 95%Catenin Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CTNND1 antibody, catalog no. 70R-2491Purity:Min. 95%FASTKD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FASTKD2 antibody, catalog no. 70R-3176Purity:Min. 95%IKZF3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of IKZF3 antibody, catalog no. 70R-8302Purity:Min. 95%C8orf77 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C8orf77 antibody, catalog no. 70R-9115Purity:Min. 95%Ppp3cb Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Ppp3cb antibody, catalog no. 70R-9510Purity:Min. 95%TREML2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TREML2 antibody, catalog no. 70R-6395Purity:Min. 95%Anti Urocortin (3-40) Serum
Anti Urocortin (3-40) Serum is a peptide that can be used as a research tool to activate ion channels and ligand receptors. This product is a high purity, lyophilized serum that can be reconstituted with water. Anti Urocortin (3-40) Serum has been shown to inhibit protein interactions in the cell biology and pharmacology fields. The CAS number for this product is 103425-75-4.Purity:Min. 95%Simian Virus 40 Large Tumor Antigen Amino-Terminal Peptide
CAS:Please enquire for more information about Simian Virus 40 Large Tumor Antigen Amino-Terminal Peptide including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formula:C46H76N14O14SMolecular weight:1,080 g/molISG20 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ISG20 antibody, catalog no. 70R-4698Purity:Min. 95%SLC29A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC29A2 antibody, catalog no. 70R-1851Purity:Min. 95%
